Ming-Jer Young
Impact in
- Infectious Diseases top 10%
- Viral Infections and Vectors
- Virology top 10%
Papers in
-
- Ubiquitin and proteasome pathways 7
- Protein Degradation and Inhibitors 2
- Epigenetics and DNA Methylation 2
- Histone Deacetylase Inhibitors Research 2
- DNA Repair Mechanisms 1
- Oncology 6
- Cancer Cells and Metastasis 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Jan‐Jong Hung (12 shared papers)Wen Chang (2 shared papers)Meng-Ti Hsieh (1 shared paper)Chuan‐Liang Kao (1 shared paper)Chwan‐Chuen King (1 shared paper)Wen‐Chang Chang (4 shared papers)Kai‐Cheng Hsu (4 shared papers)Tony Eight Lin (1 shared paper)
In The Last Decade
Ming-Jer Young
14 papers receiving 676 citations
Peers
Comparison fields: 5 of 64
- Infectious Diseases 146
- Virology 37
- Public Health, Environmental and Occupational Health 185
- Oncology 155
- Cancer Research 85
Countries citing papers authored by Ming-Jer Young
This map shows the geographic impact of Ming-Jer Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Jer Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Jer Young more than expected).
Fields of papers citing papers by Ming-Jer Young
This network shows the impact of papers produced by Ming-Jer Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Jer Young. The network helps show where Ming-Jer Young may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming-Jer Young, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 198 | |
| 2 | 2019 | 127 | |
| 3 | 2018 | 90 | |
| 4 | 2015 | 62 | |
| 5 | 2015 | 34 | |
| 6 | 2006 | 33 | |
| 7 | 2022 | 26 | |
| 8 | 2021 | 23 | |
| 9 | 2008 | 21 | |
| 10 | 2024 | 19 | |
| 11 | 2022 | 19 | |
| 12 | 2020 | 14 | |
| 13 | 2017 | 13 | |
| 14 | 2025 | 4 | |
| 15 | 2025 | 0 | |
| 16 | 2025 | 0 |
About Ming-Jer Young
Ming-Jer Young is a scholar working on Molecular Biology, Oncology, Epidemiology, Immunology and Infectious Diseases, having authored 16 papers that have together received 683 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (7 papers), Protein Degradation and Inhibitors (2 papers), Cancer Cells and Metastasis (2 papers), Epigenetics and DNA Methylation (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Peptidase Inhibition and Analysis (2 papers), DNA Repair Mechanisms (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Infectious Diseases (146 citations), Virology (37 citations), Public Health, Environmental and Occupational Health (185 citations), Oncology (155 citations) and Cancer Research (85 citations). Ming-Jer Young has collaborated with scholars based in Taiwan, India and Japan. Frequent co-authors include Jan‐Jong Hung, Wen Chang, Meng-Ti Hsieh, Chuan‐Liang Kao, Chwan‐Chuen King, Wen‐Chang Chang, Kai‐Cheng Hsu, Tony Eight Lin, Shao‐An Wang and Cheng-Yang Chou. Their work appears in journals such as Journal of Biomedical Science, Cell Death and Differentiation, Journal of Virology, Carcinogenesis and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.